$4.92
Today
as of Sep 4, 16:49 ET
Last 30 days
Recent Press Releases & News
Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 67.01%: Read This Before Placing a Bet
Here's Why Foghorn Therapeutics Inc. (FHTX) is a Great Momentum Stock to Buy
Wall Street Analysts Believe Foghorn Therapeutics (FHTX) Could Rally 88.47%: Here's is How to Trade
Overview
52-week range
$3.27
$7.61
38% of range
Avg surprise (last 3)
+2.0%
Avg reaction (last 2)
-7.7%
0% positive
Latest IV / EM
309%
EM ±48.3% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.10 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.29 | $-0.28 | -3.6% | +3.3% | -10.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.25 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-0.28 | $-0.31 | +9.7% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.30 | $-0.30 | 0.0% | — | -5.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.31 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.45 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.59 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.34 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.70 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.73 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $3M | — | $8M | $8M | $6M | — | $8M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-9M | $-22M | — | $-19M | $-21M | $-23M | — | $-24M |
| Net income | $-7M | $-20M | — | $-16M | $-18M | $-19M | — | $-19M |
| EPS (diluted) | $-0.10 | $-0.29 | — | $-0.25 | $-0.28 | $-0.30 | — | $-0.31 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $68M | $88M | $81M | $89M | $73M | $61M | $55M | $58M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $170M | $188M | $163M | $184M | $204M | $225M | $250M | $271M |
| Total assets | $203M | $222M | $198M | $205M | $226M | $259M | $284M | $308M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $284M | $299M | $307M | $295M | $303M | $320M | $330M | $337M |
| Total equity | $-81M | $-76M | $-108M | $-90M | $-77M | $-62M | $-46M | $-28M |